- $11.79m
- $38.59m
- $13.79m
- 48
- 65
- 64
- 62
Annual balance sheet for Biotricity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.2 | 12.1 | 0.57 | 0.786 | 0.365 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.85 | 2.41 | 1.81 | 1.81 | 2.72 |
Total Inventory | |||||
Total Current Assets | 4.32 | 15.3 | 4.72 | 4.47 | 4.64 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.066 | 1.27 | 1.61 | 1.24 | 0.822 |
Long Term Notes Receivable | |||||
Total Assets | 4.44 | 16.7 | 6.51 | 5.94 | 5.64 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.5 | 4.87 | 11.2 | 22.7 | 20.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.3 | 18.8 | 26.4 | 35.9 | 35.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -6.83 | -2.14 | -19.8 | -30 | -30 |
Total Liabilities & Shareholders' Equity | 4.44 | 16.7 | 6.51 | 5.94 | 5.64 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |